Log In
Print
BCIQ
Print
Print this Print this
 

Alzumab, itolizumab (T1h, Anti-CD6)

  Manage Alerts
Collapse Summary General Information
Company Biocon Ltd.
DescriptionHumanized IgG1 mAb that inhibits CD6
Molecular Target CD6
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today